NCT05431530 (LAPSODY) is a clinical trial of Cytoreductive surgery in Ovarian Cancer, sponsored by Seoul National University Hospital.

Who is sponsoring NCT05431530?

NCT05431530 is sponsored by Seoul National University Hospital.

What drugs are being tested in NCT05431530?

Interventions in NCT05431530: Cytoreductive surgery.

What condition does NCT05431530 study?

NCT05431530 studies Ovarian Cancer, Low Anterior Resection Syndrome, Quality of Life.

Is NCT05431530 still recruiting?

NCT05431530 is currently recruiting now. Last updated 27 June 2023.

Last reviewed 2023-06-27 · How we verify

NCT05431530: LAPSODY

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Assessment of Quality of Life After Low Anterior Resection During Cytoreductive Surgery for Advanced Ovarian Cancer

Recruiting now Last updated 27 June 2023

What this trial tests

trial testing Cytoreductive surgery in Ovarian Cancer in 108 participants. Currently enrolling.

Timeline

22 June 2022

Primary endpoint
31 May 2027

31 May 2027

Quick facts

Lead sponsor	Seoul National University Hospital
Status	Recruiting now
Study type	OBSERVATIONAL
Enrollment	108
Start date	22 June 2022
Primary completion	31 May 2027
Estimated completion	31 May 2027
Sites	1 location across South Korea

Drugs / interventions tested

Cytoreductive surgery

Conditions studied

Ovarian Cancer — all drugs for Ovarian Cancer →
Low Anterior Resection Syndrome — all drugs for Low Anterior Resection Syndrome →
Quality of Life — all drugs for Quality of Life →

Sponsor

Seoul National University Hospital

Who can join

18 and older, female only, with Ovarian Cancer or Low Anterior Resection Syndrome. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aims to evaluate the incidence of low anterior resection syndrome and quality of life after cytoreductive surgery for advanced ovarian cancer patients.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

From the Beginning of the Korean Gynecologic Oncology Group to the Present and Next Steps.
Min KJ, Kim NK, Song JY, Choi MC, et al · · 2024 · cited 2× · PMID 39410040 · DOI 10.3390/cancers16193422

Verify or expand the search:

Other trials of Cytoreductive surgery

Trials testing the same drug.

NCT06783491 — Efficacy of the Use of Neoadjuvant With/Without Hyperthermic Intraperitoneal Chemotherapy in the Treatment of Locally Ad · Phase 3 · not yet recruiting
NCT07177105 — Primary Tumor Resection With Sintilimab and Chemotherapy in Advanced NSCLC · Phase 2 · not yet recruiting
NCT05375825 — Phase I Evaluation of Immunotoxin LMB-100 Administered by Normothermic, Intrapleural Perfusion Following Cytoreductive S · Phase 1 · withdrawn
NCT06223763 — SUROVA - Surgery in Ovarian Cancer, Comparing Primary and Interval Cytoreductive Surgery · unknown
NCT06292286 — Secondary Interval Cytoreductive Surgery in Platinum-sensitive Recurrent Epithelial Ovarian Cancer · NA · recruiting

Other recruiting trials for Ovarian Cancer

Currently open trials in the same condition.

NCT06412120 — Study Evaluating Safety, Tolerability, and Metabolism of Niraparib · Phase 4 · recruiting
NCT06930755 — Study of NMS-03305293 in Adult Patients With Relapsed Ovarian Cancer · Phase 1 · recruiting
NCT07318558 — A Clinical Trial of Sac-TMT in People With Non-HRD Positive Advanced Ovarian Cancer (MK-2870-021) · Phase 3 · recruiting
NCT07491081 — EARLY Study: Evaluating the Specificity and Feasibility of the EARLY Biomarker Panel for Ovarian Cancer Detection · NA · recruiting
NCT07410676 — EBNK-001 Allogeneic NK Cells With Low-Dose IL-15 ± Pembrolizumab in Advanced Solid Tumors · Phase 1, PHASE2 · recruiting

Other Seoul National University Hospital trials

Trials by the same sponsor.

NCT07262944 — EOI Block in Otoplasty With Rib Cartilage Graft · NA · recruiting
NCT07464210 — Nemtabrutinib, Bortezomib, and Rituximab for WM · Phase 2 · not yet recruiting
NCT07550803 — Effect of Intraoperative Dexamethasone on Early Postoperative Sleep Quality in Patients Undergoing Nasal Surgery · NA · not yet recruiting
NCT07522138 — Home-based Self-exercise in Patients With Parkinson's Disease: A Feasibility Study · NA · not yet recruiting
NCT07476651 — Scout Dose of Resin Microspheres · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05431530 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Seoul National University Hospital
Last refreshed: 27 June 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05431530.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing